Literature DB >> 3041051

Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression.

M O Oguro, N Shimizu, Y Ono, K Takada.   

Abstract

The BamHI M DNA fragment of Epstein-Barr virus was shown to activate transcription of the cotransfected chloramphenicol acetyltransferase gene under the control of the simian virus 40 early promoter. Both the BamHI-BglII and the HindIII-BamHI subfragments of the BamHI M fragment, corresponding to the rightward reading frame BMRF1 and the leftward reading frame BMLF1, respectively, had the ability to activate transcription from the simian virus 40 promoter. The trans-activating function was well correlated with the expression of nuclear early antigens, which suggests that early antigens encoded by BMRF1 and BMLF1 are responsible for trans-activation and possibly play a role in regulated expression of virus genomes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041051      PMCID: PMC255915          DOI: 10.1128/JVI.61.10.3310-3313.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation.

Authors:  N Mueller-Lantzsch; N Yamamoto; H zur Hausen
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

2.  Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

Authors:  J Luka; B Kallin; G Klein
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

3.  Activation of latent Epstein-Barr virus by antibody to human IgM.

Authors:  M G Tovey; G Lenoir; J Begon-Lours
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

4.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

5.  Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).

Authors:  P Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

6.  Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).

Authors:  B Hampar; J G Derge; L M Martos; J L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

7.  Complementation and transformation by temperature-sensitive mutants of polyoma virus.

Authors:  W Eckhart
Journal:  Virology       Date:  1969-05       Impact factor: 3.616

8.  The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines.

Authors:  L Gergely; G Klein; I Ernberg
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

9.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  14 in total

1.  Identification of a protein encoded in the EB-viral open reading frame BMRF2.

Authors:  S Modrow; B Höflacher; H Wolf
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Structure and function of the Epstein-Barr virus BZLF1 protein.

Authors:  G Packham; A Economou; C M Rooney; D T Rowe; P J Farrell
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein.

Authors:  S Metzenberg
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

4.  Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Authors:  Q Zhang; Y Hong; D Dorsky; E Holley-Guthrie; S Zalani; N A Elshiekh; A Kiehl; T Le; S Kenney
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Relative rates of RNA synthesis across the genome of Epstein-Barr virus are highest near oriP and oriLyt.

Authors:  S Metzenberg
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.

Authors:  S Kenney; J Kamine; E Holley-Guthrie; J C Lin; E C Mar; J Pagano
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Identification of proteins encoded by Epstein-Barr virus trans-activator genes.

Authors:  M Marschall; U Leser; R Seibl; H Wolf
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.

Authors:  K Takada; Y Ono
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

9.  Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.

Authors:  N Shimizu; K Takada
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Regulation of the herpesvirus saimiri (HVS) delayed-early 110-kilodalton promoter by HVS immediate-early gene products and a homolog of the Epstein-Barr virus R trans activator.

Authors:  J Nicholas; L S Coles; C Newman; R W Honess
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.